Illumina, Inc.
Provider of genomic sequencing instruments, consumables, and informatics with capabilities spanning next-generation sequencing (benchtop to production), microarrays, library preparation workflows, clinical sequencing services (including noninvasive prenatal screening and clinical whole-genome sequencing), and bioinformatics pipelines. Offers instrument support, training, advisory services, and medical education and research grant support for research, clinical, public-health, agrigenomics, and population-scale genomics programs.
Industries
Nr. of Employees
Very Large (1000+)
Illumina, Inc.
14F iM Investment & Securities building, 66 Yeoidaero, Yeoungdeungpo-gu, Seoul, Korea 07325
Products
Sequencing platforms and instrument reagent kits
A portfolio of sequencing systems and associated reagent kits for targeted, whole-genome, and high-throughput sequencing applications across research and clinical use cases.
High-density genotyping microarrays (including pharmacogenomics content)
Microarray assays and scanning systems for large-scale genotyping, including arrays with enhanced pharmacogenomics marker content and workflows for star-allele calling and metabolizer status reporting.
Custom and consortia genotyping arrays for agrigenomics
Pre-designed and custom genotyping arrays developed for crop, livestock, and companion-animal genomics, often delivered through collaborative consortia and supported by array-design tools.
Sequencing platforms and instrument reagent kits
A portfolio of sequencing systems and associated reagent kits for targeted, whole-genome, and high-throughput sequencing applications across research and clinical use cases.
High-density genotyping microarrays (including pharmacogenomics content)
Microarray assays and scanning systems for large-scale genotyping, including arrays with enhanced pharmacogenomics marker content and workflows for star-allele calling and metabolizer status reporting.
Custom and consortia genotyping arrays for agrigenomics
Pre-designed and custom genotyping arrays developed for crop, livestock, and companion-animal genomics, often delivered through collaborative consortia and supported by array-design tools.
Services
End-to-end sequencing services for research and clinical applications, including sample collection (barcoded kits), sequencing, validated analysis, and secure delivery of results from accredited clinical laboratories.
Provision of software platforms, on-premise and cloud analytics, and accelerated secondary analysis pipelines for sequence processing, variant calling, and cohort-level analyses.
On-site and remote service contracts for instrument installation qualification, preventive maintenance, proactive performance monitoring, and technical support.
Consulting and program support for design and implementation of population-scale genomics initiatives, covering lab workflows, informatics architecture, governance, and economic modeling.
End-to-end sequencing services for research and clinical applications, including sample collection (barcoded kits), sequencing, validated analysis, and secure delivery of results from accredited clinical laboratories.
Provision of software platforms, on-premise and cloud analytics, and accelerated secondary analysis pipelines for sequence processing, variant calling, and cohort-level analyses.
On-site and remote service contracts for instrument installation qualification, preventive maintenance, proactive performance monitoring, and technical support.
Consulting and program support for design and implementation of population-scale genomics initiatives, covering lab workflows, informatics architecture, governance, and economic modeling.
Expertise Areas
- Next-generation sequencing platforms and reagents
- Clinical genomics and diagnostic sequencing (accredited laboratory operations)
- Noninvasive prenatal screening (cfDNA, genome-wide NIPT)
- Microbial genomics and public-health genomic surveillance
Key Technologies
- Next-generation sequencing (NGS)
- Sequencing-by-synthesis chemistry
- Whole-genome cfDNA sequencing for screening
- Paired-end sequencing
News & Updates
Webinar focused on instrument monitoring and utilization to reduce downtime.
Feature article on a partnership supporting Brain Fest at Science Centre Singapore and STEM outreach efforts.
Research publication describing integrated NGS approaches for genotyping relevant to carrier screening.
Reported installed base of more than 22,000 systems and over 300,000 studies driven by the company's technology (2022 reference).
Reported portfolio of approximately 9,000 patents.
Reported annual revenue of $4.3B USD (as of 2024).
Webinar focused on instrument monitoring and utilization to reduce downtime.
Feature article on a partnership supporting Brain Fest at Science Centre Singapore and STEM outreach efforts.
Research publication describing integrated NGS approaches for genotyping relevant to carrier screening.
Reported installed base of more than 22,000 systems and over 300,000 studies driven by the company's technology (2022 reference).
Reported portfolio of approximately 9,000 patents.
Reported annual revenue of $4.3B USD (as of 2024).